DOCSLIB.ORG

Manual of Patent Practice and Procedure the Patent Office, India

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

INTELLECTUAL PROPERTY INDIA PATENTS || DESIGNS || TRADEMARKS || GEOGRAPHICAL INDICATIONS MANUAL OF PATENT PRACTICE AND PROCEDURE THE PATENT OFFICE, INDIA Intellectual Property Office, Mumbai Intellectual Property Office, Delhi Intellectual Property Office, Chennai Intellectual Property Office, Kolkata Office of the Controller General of Patents, Designs & Trade Marks Boudhik Sampada Bhawan S.M. Road, Antop Hill Mumbai – 400 037. Patent Office, Kolkata (Head Office) Boudhik Sampada Bhawan CP-2, Sector V, Salt Lake City Kolkata – 700 091. Patent Office, Chennai Intellectual Property Building G.S.T. Road, Guindy Chennai – 600 032. Patent Office, Delhi Boudhik Sampada Bhawan Plot No.32, Sector-14, Dwarka New Delhi – 110 075. Patent Office, Mumbai Boudhik Sampada Bhawan S.M. Road, Antop Hill Mumbai – 400 037. Third Edition – 2008 Manual of Patent Practice & Procedure © Controller General of Patents, Designs & Trade Marks, India. 2 PREFACE This Manual is intended to provide detailed information to the public and users of Patent System on the practices and procedures followed by Patent Office for processing of patent applications. The Manual incorporates provisions of the Patents Act, 1970 as amended by the Patents (Amendment) Act, 2005 and the Patents Rules, 2003 as amended by the Patents (Amendment) Rules, 2006. The format of the Manual is to reproduce successive sections and relevant rules of the Patents Act and Patents Rules followed by explanation and past decisions of the Patent Office, wherever available. References to decisions of the courts of India and other countries have been included to provide guidance and help the users. The Manual does not constitute rule making and hence do not have the force and effect of law. Statements made in the Manual are not in themselves an authority for any action by an officer of the Patent Office. While the Manual may be regarded as a guide, it does not impose any particular line of such action and may not be quoted to that end. The Manual will be updated periodically in order to reflect important judgments, decisions and changes in practice and to correct errors, if any. Due care has been taken to avoid mistakes. However, if any shortcomings are noticed by the users, suggestions to improve the Manual will be appreciated. (V. RAVI) Controller General of Patents, Designs &Trade Marks 3 CONTENTS Chapter I: Introduction 6-60 - Origin of the Patent System - History of Indian Patent System - Patent Administration in India - Patentable subject matter - Novelty - Inventive Step - Industrial Applicability Chapter II: Non-patentable Subject Matter 60-91 -Inventions related to Atomic Energy Chapter III: Application for Patents 92-162 - Persons entitled to apply - Where to apply? - How to apply? - Statement and Undertaking regarding Foreign Filing - Types of Patent Applications - Specification and Drawings - Provisional Specification - Complete Specification - Unity of Invention - Sufficiency of Disclosure - Structure of Claims - Drawings - Claims - Markush- type of claims - General Guidelines for the Applicant Chapter IV:Publication and Examination of Applications 163-203 - 18-month Publication - Early Publication - Request for Examination - Guidelines for Formal Examination - Technical Examination - Priority of Claims 4 - Strategy for Novelty Search - Issue of FER and Procedures Thereafter - Change of Applicant - Amendment of Application and Specification - Time for putting the application in order for Grant Chapter V: Opposition Proceedings to Grant of Patents 204-238 - Pre-grant Opposition by Representation - Post-grant Opposition - Action in case of wrongful obtaining Chapter VI: Anticipation 239-245 Chapter VII: Secrecy Directions for Inventions Related 246-252 to Defence Chapter VIII: Grant of Patents 253-263 Chapter IX: Patent of Addition 264-267 Chapter X:Amendment of Applications & Specifications 268-278 Chapter XI: Restoration of Lapsed Patents 279-284 Chapter XII: Surrender and Revocation of Patents 285-306 Chapter XIII: Register of Patents 307-316 Chapter XIV: Patent Office & its Establishment 317-320 Chapter XV: Powers of Controller 321-327 Chapter XVI: Working of Patents and 328-353 Compulsory Licenses Chapter XVII: Use of Inventions by Government 354-360 And acquisition of invention by Central Government Chapter XVIII: Suit Concerning Infringement of Patents 361-363 Chapter XIX: Appellate Board 364-368 Chapter XX: Penalties 369-373 Chapter XXI: Patent Agents 374-386 Chapter XXII: International Arrangements 387-393 Chapter XIII : Miscellaneous Provisions 394-402 Annexure 1 The First Schedule (Fees) 403-402 5 Annexure 2 PCT Fees 407-408 Annexure 3 Forms 409-434 6 CHAPTER I Introduction The Patent System in India 1.1 A patent is granted as an exclusive right by the Government for an invention, for a limited period of time in consideration of disclosure of the invention by an applicant. A patentee enjoys exclusive right to prevent the third party from unauthorized act of making, using, offering for sale, selling or importing the patented product or process within the country during the term of the patent. A patented invention becomes free for public use after expiry of the term of the patent or when the patent ceases to have effect, by non-payment of any renewal fee. 1.2 History of Indian Patent System 1.2.1 The first legislation in India relating to patents was the Act VI of 1856. The objective of this legislation was to encourage inventions of new and useful manufactures and to induce inventors to disclose secret of their inventions. The Act was subsequently repealed by Act IX of 1857 since it had been enacted without the approval of the sovereign. Fresh legislation for granting ‘exclusive privileges’ was introduced in 1859 as Act XV of 1859. This legislation contained certain modifications of the earlier legislation, namely, grant of exclusive privileges to useful inventions only and extension of priority period from 6 months to 12 months. This Act excluded importers from the definition of inventor. This Act was based on the United Kingdom Act of 1852 with certain departures including allowing assignees to make application in India and also taking prior public use or publication in India or United Kingdom for the purpose of ascertaining novelty. 1.2.2 In 1872, the Act of 1859 was revisited to provide protection relating to designs. It was renamed as “The Patterns and Designs Protection Act” under Act XIII of 1872. The Act of 1872 was amended in 1883 (XVI of 1883) to introduce a provision to protect novelty of the invention, which prior to making application for their protection were disclosed in the Exhibition of India (?). A grace period of 6 months was provided for filing such applications after the date of the opening of such Exhibition. 1.2.3 This Act remained in force for about 30 years without any change but in the year 1883, certain modifications in the patent law were made in United Kingdom (UK) and it was considered that those modifications should also be incorporated in the Indian law. In 1888, new legislation was introduced to consolidate and amend the law relating to invention and designs in conformity with the amendments made in the U.K. law. The modifications introduced in the Indian law, by Act V of 1888, over the UK legislation, inter alia, includes: • Shifting of authority to administer the Act from the Home department to Secretary to Government of India; 7 • Extension of the jurisdiction of the Act to other courts apart from High Courts of Madras, Calcutta and Bombay; • Reduction in the fee; • Provision for detailed disclosure of the invention, including best mode of working the invention in full clear, concise and exact terms so as to enable any person skilled in the art or science to make use of the invention; • Provision of powers to call for a model of the invention; • Change of time for filing petition in respect of patent granted in United Kingdom from 12 months from the ‘letters patent’ to 12 months from the ‘date of sealing’; • Extension of term of exclusive privileges to ------ • Provision for granting compulsory licence where invention is not made accessible to public, on reasonable terms; • Appointment of Agents to encourage filing by foreign inventor; • Introduction of provision for protection of new or original design; • Provision for counting the grace period for filing application for invention displayed in the Exhibition from the date of admission of the invention into the Exhibition instead of the date of the opening of the Exhibition. 1.2.4 In 1911, the Indian Patents and Designs Act, 1911, (Act II of 1911) was brought in replacing all the previous Acts. This Act brought patent administration under the management of Controller of Patents for the first time. This Act was amended in 1920 to provide for entering into reciprocal arrangements with UK and other countries for securing priority. In 1930, further amendments were made to incorporate, inter-alia, provisions relating to grant of secret patents, patent of addition, use of invention by Government, powers of the Controller to rectify register of patent and increase of term of the patent from 14 years to 16 years. In 1945, another amendment was made to provide for filing of provisional specification and submission of complete specification within nine months. 1.2.5 After Independence, it was felt that the Indian Patents & Designs Act, 1911 was not fulfilling its objective. It was found desirable to enact comprehensive patent law owing to substantial changes in political and economic conditions
Recommended publications
  • I-Link for Access Code on the AIA/14

    I-Link for Access Code on the AIA/14

    i-link for Access Code on the AIA/14 Q1. What is an Access Code? A1. Data that used together with the application number and filing date to uniquely identify a patent application that is registered into the WIPO DAS (World Intellectual Property Organization Digital Access Service). As of March 18, 2013, all WIPO DAS participating offices require that the access code be provided in order to retrieve the priority document. Q2. When is an Access Code required? A2. When the following conditions are met: (1) The foreign priority application is filed in a foreign intellectual property office that is a participating WIPO DAS depositing office; (2) Appropriate steps have been taken by the applicant to make the priority application available to the Office via the WIPO DAS; and, (3) The applicant wishes the Office to attempt electronic retrieval of the priority application. Q3. What format should be used on the Application Data Sheet (ADS) Foreign Priority Information section? A3. The application number and access code format are determined by the DAS participating office. Sample application number formats can be found on the USPTO Website at https://www.uspto.gov/sites/default/files/documents/ADSSampleFormat.pdf Q4. Will the Office notify the applicant when an Access Code is required, but not furnished? A4. When an applicant claims priority to a foreign application filed in a WIPO DAS depositing office and fails to provide the required access code, the U.S. application filing receipt will include an indication “No Access Code Provided” adjacent to the foreign application number. Q5. Will the Office notify the applicant that retrieval of the priority document will be attempted? A5.
  • Indian Patent Law and Novartis AG V. Union of India

    Indian Patent Law and Novartis AG V. Union of India

    TRIALS AND TRIPS-ULATIONS: INDIAN PATENT LAW AND No VAR TIS A G v. UNION OF INDIA By Linda L Lee I. INTRODUCTION When pharmaceutical company Novartis challenged the rejection of its patent application for the leukemia drug Gleevec in Novartis A G v. Union of India,' it became the first major legal challenge to India's newly amended patent law. In 2005, India purportedly made the final changes required to bring its intellectual property laws in compliance with the Trade-Related Aspects of Intellectual Property Rights (TRIPS), the World Trade Organization's (WTO) minimum standards for intellectual property protection, 2 but its patent law is still fraught with a number of controver- sial provisions. The ability of pharmaceutical companies such as Novartis to secure patent protection in India not only is important in creating incen- tives for pharmaceutical research, but also greatly affects the Indian ge- neric drug industry, and therefore the price of medicine available to pa- tients. India is the world's second most populous country3 and the second- fastest growing major economy,4 but has 70% of its population living on less than $2 per day,5 making Novartis A G of paramount importance. © 2008 Linda L. Lee. 1. Novartis AG v. Union of India, (2007) 4 MADRAS L.J. 1153, available at http://www.scribd.com/doc/456550/High-Court-order-Novartis-Union-of-India. 2. Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, Le- gal Instruments-Results of the Uruguay Round, 33 I.L.M.
  • India: Effects of Tariffs and Nontariff Measures on U.S. Agricultural Exports

    India: Effects of Tariffs and Nontariff Measures on U.S. Agricultural Exports

    United States International Trade Commission India: Effects of Tariffs and Nontariff Measures on U.S. Agricultural Exports Investigation No. 332-504 USITC Publication 4107 November 2009 U.S. International Trade Commission COMMISSIONERS Shara L. Aranoff, Chairman Daniel R. Pearson, Vice Chairman Deanna Tanner Okun Charlotte R. Lane Irving A. Williamson Dean A. Pinkert Robert A. Rogowsky Director of Operations Karen Laney-Cummings Director, Office of Industries Address all communications to Secretary to the Commission United States International Trade Commission Washington, DC 20436 U.S. International Trade Commission Washington, DC 20436 www.usitc.gov India: Effects of Tariffs and Nontariff Measures on U.S. Agricultural Exports Investigation No. 332-504 Publication 4107 November 2009 This report was prepared principally by the Office of Industries Project Leader George S. Serletis [email protected] Deputy Project Leader Brian Allen [email protected] Laura Bloodgood, Joanna Bonarriva, John Fry, John Giamalva, Katherine Linton, Brendan Lynch, and Marin Weaver Primary Reviewers Alexander Hammer and Deborah McNay Office of Economics Michael Ferrantino, Jesse Mora, Jose Signoret, and Marinos Tsigas Administrative Support Phyllis Boone, Monica Reed, and Wanda Tolson Under the direction of Jonathan R. Coleman, Chief Agriculture and Fisheries Division Abstract This report describes and analyzes policies and other factors that affect U.S. agricultural exports to India. The findings suggest that India’s high agricultural tariffs are a significant impediment to U.S. agricultural exports and that certain Indian nontariff measures (NTMs), including sanitary and phyosanitary measures, substantially limit or effectively prohibit certain U.S. agricultural products. Agriculture is vital to India’s economy, accounting for a substantial share of employment (60 percent) and GDP (17 percent).
  • Post-2005 TRIPS Scenario in Patent Protection in the Pharmaceutical Sector

    Post-2005 TRIPS Scenario in Patent Protection in the Pharmaceutical Sector

    Post-2005 TRIPS scenario in patent protection in the pharmaceutical sector: The case of the generic pharmaceutical industry in India BISWAJIT DHAR Professor and Head Centre for WTO Studies Indian Institute for Foreign Trade India And K.M. GOPAKUMAR Centre for Trade and Development India November, 2006 Post-2005 TRIPS scenario in patent protection in the pharmaceutical sector: The case of the generic pharmaceutical industry in India Biswajit DHAR International Centre for Trade and Sustainable Development (ICTSD) International Environnement House 2 7 Chemin de Balexert, 1219 Geneva, Switzerland Tel: +41 22 917 8492 Fax: +41 22 917 8093 E-mail: [email protected] Internet: www.ictsd.org United Nations Conference on Trade and Development (UNCTAD) Palais de Nations 8 – 14 avenue de la Paix, 1211 Geneva, Switzerland Tel : +41 22 907 1234 Fax : +41 22 9070043 Email: [email protected] Internet: www.unctad.org International Development Research Centre (IDRC) 250 Albert Street Ottawa, ON, Canada K1P 6M1 Phone: (+1-613) 236-6163 Fax: (+1-613) 238-7230 e-mail: [email protected] Internet: www.idrc.ca Programme Team (ICTSD): David Vivas-Eugui, Pedro Roffe, Gina Vea, Preeti Ramdasi Project Team (UNCTAD): James Zhan, Kiyoshi Adachi and Christoph Spennemann Programme Team (IDRC): Randy Spence, Stephen McGurk, Jaqueline Loh Acknowledgment: Funding for the UNCTAD/ICTSD Project on Intellectual Property Rights and Sustainable Development has been generously provided by DFID, IDRC, SIDA and the Rockefeller Foundation. The broad aim of this Programme is to improve the understanding of intellectual property rights related issues among developing countries and to assist them in building their capacity for ongoing as well as future negotiations on intellectual property rights.
  • Patent Cooperation Treaty (PCT) Working Group

    Patent Cooperation Treaty (PCT) Working Group

    Annex 1 E PCT/WG/11/27 ORIGINAL: ENGLISH DATE: JANUARY 11, 2019 Patent Cooperation Treaty (PCT) Working Group Eleventh Session Geneva, June 18 to 22, 2018 REPORT adopted by the Working Group 1. The Patent Cooperation Treaty Working Group held its eleventh session in Geneva from June 18 to 22, 2018. 2. The following members of the Working Group were represented at the session: (i) the following Member States of the International Patent Cooperation Union (PCT Union): Algeria, Australia, Austria, Belarus, Brazil, Bulgaria, Canada, Chile, China, Colombia, Côte d’Ivoire, Czech Republic, Democratic People’s Republic of Korea, Denmark, Ecuador, Egypt, El Salvador, Finland, France, Georgia, Germany, Greece, Guatemala, Honduras, Hungary, India, Indonesia, Iran (Islamic Republic of), Israel, Italy, Japan, Kazakhstan, Kuwait, Lithuania, Malaysia, Malta, Mexico, Montenegro, Morocco, Nigeria, Norway, Oman, Peru, Philippines, Poland, Portugal, Republic of Korea, Romania, Russian Federation, Saudi Arabia, Senegal, Singapore, Slovakia, South Africa, Spain, Sudan, Sweden, Switzerland, Thailand, Trinidad and Tobago, Turkey, Uganda, Ukraine, United Arab Emirates, United Kingdom, United States of America, Uzbekistan, Viet Nam, Zimbabwe (69); and (ii) the following intergovernmental organizations: the European Patent Office (EPO), the Nordic Patent Institute (NPI), and the Visegrad Patent Institute (VPI) (3). 3. The following Member States of the International Union for the Protection of Industrial Property (Paris Union) participated in the session as an observer: Mauritius, Yemen (2). 4. The following intergovernmental organizations were represented by observers: African Intellectual Property Organization (OAPI), African Regional Intellectual Property Organization (ARIPO), African Union (AU), Eurasian Patent Organization (EAPO), European Union (EU), Patent Office of the Cooperation Council for the Arab States of the Gulf (GCC Patent Office), South Centre (7).
  • Trademark Examination Guidelines

    Trademark Examination Guidelines

    STATE INTELLECTUAL PROPERTY OFFICE OF THE REPUBLIC OF CROATIA TRADEMARK EXAMINATION GUIDELINES December 2014 SIPO Trademark Examination Guidelines Contents Contents CHAPTER I INTRODUCTION AND LEGAL FRAMEWORK 1 1.1 Introduction 1 1.2 Legal Framework 1 CHAPTER II RECEIPT OF APPLICATIONS AND FORMALITIES EXAMINATION 3 2.1 Receipt of Application 3 2.2 Accordance of a Filing Date of an Application 3 2.2.1 Requirements 3 2.2.2 Remedy of Deficiencies (Article 22 of the Act) 4 2.3 Additional Requirements 4 2.3.1 Applicant 5 2.3.1.1 Applicant’s Name and Address (Article 32 of the Regulations) 6 2.3.2 Representative 6 2.3.2.1 Representative’s Name and Address (Article 32 paragraphs 2 and 4 of the Regulations) 7 2.3.2.2 Power of Attorney 7 2.3.3 Indication and List of the Goods and Services (Article 2, paragraphs 1 and 2, and Article 10, paragraph 1 of the Regulations) 7 2.3.4 Priority Right 7 2.3.4.1 Union Priority Right (Article 18 of the Act) 7 2.3.4.2 Exposition Priority Right (Article 19 of the Act) 8 2.3.5 Indication and Representation of a Sign 9 2.3.5.1 Verbal Sign (Article 3 of the Regulations) 9 2.3.5.2 Figurative Sign (Article 4 of the Regulations) 9 2.3.5.3 Three-dimensional Sign . (Article 5 of the Regulations). 9 2.3.5.4 Signs Consisting of one Colour or of a Combination of Colours (Article 6 of the Regulations) 10 2.3.5.5 Other Types of Signs (Article 7 of the Regulations) 10 2.3.5.6 Other Requirements Concerning the Representation of a Sign (Article 8 of the Regulations) 10 2.3.5.7 Attachments to the Application (Article 9 of the
  • Preparation for Accelerated Examination of Patent Application in India It Takes on Average 7 Years from Application to Registrat

    Preparation for Accelerated Examination of Patent Application in India It Takes on Average 7 Years from Application to Registrat

    Column No.19 Preparation for Accelerated Examination of Patent Application in India 【2013/6/19】 ------------------------------------------------------------------------------------------------------ Preparation for Accelerated Examination of Patent Application in India Hiroyuki Hashimoto, Patent Attorney, Deputy Director, Miyoshi & Miyoshi Osamu Kubori, Foreign Services Division Chief, Miyoshi & Miyoshi Vinit Bapat, Indian Patent Attorney, Managing Director, Sangam IP Recently, for Japanese enterprises, India is positioned as not only a production base aimed at the Indian domestic market but also as an exporting base for Africa and the Middle East, taking advantage of its geographical location. Also, law offices dealing with intellectual properties in India are taking advantage of the country's geographical strengths to not merely provide services relating to intellectual property protection within India. In addition, they have positively built up a network including neighboring countries, and are seeking retention of overseas customers. In light of these circumstances alone, the significance of India is great as a base for IP strategy from South East Asia to the west, and many Japanese enterprises focus attention on the importance of obtaining intellectual property rights, such as patents, in India. However, under current circumstances, from initial application to the start of an examination takes a long time in India so applicants face a problem in trying to accelerate important applications. Therefore, we propose measures that can contribute to accelerated examination of patent applications in India. It takes on average 7 years from application to registration in India, which has no accelerated examination system India has four Patent Offices (Calcutta, Mumbai, Delhi, and Chennai) and enables overseas residents to file a patent application with any of the Patent Offices by selecting a local agent (patent attorney).
  • Patent Agent Examination Guidebook

    Patent Agent Examination Guidebook

    IIPTA Indian Institute of Patent and Trademark Patent Agent Examination Guidebook Patent Agent Examination Preparation Guidebook Compiled by: Indian Institute Of Patent and Trademark Disclaimer: IIPTA and Indian Institute of Patent and Trademark are brands of Indian Institute of Patent and Trademark Education and Research Private Limited, a privately held company. IIPTA is not affiliated to Indian government and Indian patent and trademark office. Indian Institute of Patent and Trademark 1 Contents What is Patent Agent Exam? ........................................................................................ 3 17 most asked questions about Patent Agent Examination ...................................... 4 10 myths about Patent Agent Examination............................................................... 12 Top 8 questions about what is the salary of the Registered Patent Agent in India 18 Indian Institute of Patent and Trademark 2 What is Patent Agent Exam? Patent Agent Exam is conducted by Government of India. After qualifying the examination, professionals can start practicing as patent agents and help corporates and individuals filing patents. Indian Institute of Patent and Trademark 3 17 most asked questions about Patent Agent Examination Question 1: What is the eligibility criterion for appearing in Patent Agent Exam conducted by Indian Patent Office – Age, Qualification, and Citizenship etc.? Eligibility criteria to appear in the Indian Patent Agent Exam are simple and as follows: Minimum 21 years Indian Nationality Minimum one science based graduation [degree in science, engineering or technology from any university established under law in India or possesses such other equivalent qualifications as the Central Government may specify in this behalf – BSc, MSc, B. Pharma, M. Pharma, BE, ME, B.Tech, M.Tech, PhD, MBBS etc (this is just a small list of degrees qualifying for Indian Patent Agent Exam and may not be complete.
  • Guidelines for Examination in the European Patent Office

    Guidelines for Examination in the European Patent Office

    GUIDELINES FOR EXAMINATION IN THE EUROPEAN PATENT OFFICE Published by the European Patent Office Published by the European Patent Office Directorate Patent Law 5.2.1 D-80298 Munich Tel.: (+49-89) 2399-4512 Fax: (+49-89) 2399-4465 Printed by: European Patent Office, Munich Printed in Germany © European Patent Office ISBN 3-89605-074-5 a LIST OF CONTENTS page General Part Contents a 1. Preliminary remarks 1 2. Explanatory notes 1 2.1 Overview 1 2.2 Abbreviations 2 3. General remarks 3 4. Work at the EPO 3 5. Survey of the processing of applications and patents at the EPO 4 6. Contracting States to the EPC 5 7. Extension to states not party to the EPC 5 Part A – Guidelines for Formalities Examination Contents a Chapter I Introduction I-1 Chapter II Filing of applications and examination on filing II-1 Chapter III Examination of formal requirements III-1 – Annex List of Contracting States to the Paris Convention (see III, 6.2) III-20 Chapter IV Special provisions IV-1 Chapter V Communicating the formalities report; amendment of application; correction of errors V-1 Chapter VI Publication of application; request for examination and transmission of the dossier to Examining Division VI-1 Chapter VII Applications under the Patent Cooperation Treaty (PCT) before the EPO acting as a designated or elected Office VII-1 Chapter VIII Languages VIII-1 Chapter IX Common provisions IX-1 Chapter X Drawings X-1 Chapter XI Fees XI-1 Chapter XII Inspection of files; communication of information contained in files; consultation of the Register of European
  • Patent Cooperation Treaty for Private Applicants | 19

    Patent Cooperation Treaty for Private Applicants | 19

    Patent Cooperation Treaty (PCT) for Private Applicants 1 June 2021 Intellectual Property Office is an operating name of the Patent Office 1 | Intellectual Property Office Patent Cooperation Treaty (PCT) GB Receiving Office Notes for Private Applicants This note is intended to serve as a basic introduction to filing International patent applications under the Patent Cooperation Treaty (PCT) with the GB Receiving Office at the Intellectual Property Office. Whilst we have made every effort to cover important aspects this note is not comprehensive and you are advised to read the various PCT Guides issued by WIPO (World Intellectual Property Organisation) and to seek advice when in doubt. THE PCT SYSTEM IS COMPLEX. YOU ARE STRONGLY ADVISED TO SEEK THE HELP OF A CHARTERED PATENT AGENT. Deadlines A chart showing the timelines for action on your application is attached at ANNEX B. Reminders will not be issued at any stage during the processing of your application and failure to meet deadlines may mean you incurring surcharges or even losing your application. 2 | Intellectual Property Office Introduction The Patent Cooperation Treaty (PCT) system allows applicants seeking patent protection, in a number of countries, to file a single international application in English with the Intellectual Property Office. The International Unit at the Intellectual Property Office acts as the GB Receiving Office under the PCT. A PCT application has the same effect as a regular filing in each of the national or regional Offices of the PCT Contracting States that you select or designate when you complete the PCT Request form PCT/RO/101. Your PCT application is processed through 2 basic stages, the International Phase and the National (for example: seeking a national UK patent) or Regional Phase (for example: seeking a regional European patent).
  • Taking Care of Article 6Bisness: How Belmora LLC V. Bayer Consumer Care AG Made the Well-Known Mark Doctrine Inevitable in the U.S

    Taking Care of Article 6Bisness: How Belmora LLC V. Bayer Consumer Care AG Made the Well-Known Mark Doctrine Inevitable in the U.S

    Washington Journal of Law, Technology & Arts Volume 12 | Issue 4 Article 4 4-1-2017 Taking Care of Article 6bisness: How Belmora LLC v. Bayer Consumer Care AG Made the Well-Known Mark Doctrine Inevitable in the U.S. Gwen Wei Follow this and additional works at: https://digitalcommons.law.uw.edu/wjlta Part of the Intellectual Property Law Commons Recommended Citation Gwen Wei, Taking Care of Article 6bisness: How Belmora LLC v. Bayer Consumer Care AG Made the Well-Known Mark Doctrine Inevitable in the U.S., 12 Wash. J. L. Tech. & Arts 501 (2017). Available at: https://digitalcommons.law.uw.edu/wjlta/vol12/iss4/4 This Article is brought to you for free and open access by the Law Reviews and Journals at UW Law Digital Commons. It has been accepted for inclusion in Washington Journal of Law, Technology & Arts by an authorized editor of UW Law Digital Commons. For more information, please contact [email protected]. Wei: Taking Care of Article 6<i>bis</i>ness: How <i>Belmora LLC v. Bay WASHINGTON JOURNAL OF LAW, TECHNOLOGY & ARTS VOLUME 12, ISSUE 4 SPRING 2017 TAKING CARE OF ARTICLE 6BISNESS: HOW BELMORA LLC V. BAYER CONSUMER CARE AG MADE THE WELL-KNOWN MARK DOCTRINE INEVITABLE IN THE U.S. Gwen Wei* © Gwen Wei CITE AS: 12 WASH. J.L. TECH. & ARTS 501 (2017) http://digital.law.washington.edu/dspace-law/handle/1773.1/1793 ABSTRACT In Belmora LLC v. Bayer Consumer Care AG, the Fourth Circuit held that a foreign company with no U.S. federal trademark registration for "FLANAX" could nevertheless demand cancellation of its competitor's U.S.
  • Escribe Agenda Package

    Escribe Agenda Package

    TOWNSHIP OF CHAMPLAIN REGULAR MEETING October 8, 2020 Electronic Participation 1. OPENING - 7:00 P.M. Call to order. 2. DISCLOSURE OF PECUNIARY INTEREST (on any items that appear on the agenda) 3. ADOPTION OF AGENDA 4. PRESENTATION BY COUNCIL 5. PRESENTATION − COMMITTEES / CONSULTANTS 6. DEPUTATION 7. STAFF REPORTS 7.1. Planning 7.1.1. On-Going Planning Projects 7.1.2. Zoning By-Law Amendment Application - Removal of "Holding" zone (h) - Habitations Robert Inc. 7.1.3. Land Severance Application B-053-2020 - 853853 Ontario Inc. / Andre Desjardins 7.1.4. Land Severance Application B-054-2020 and B-055-2020 - Voith Canada Inc. 7.1.5. Land Severance Application B-056-2020, B-057-2020 et B-058-2020 - Ridge Holdings Inc. / John Russell 7.2. ADOPTION OF PLANNING BY-LAWS 7.2.1. By-Law 2020-62 - to amend Zoning By-Law 2000-75 - Habitations Robert Inc. 7.3. Administration 7.3.1. Administration Report AD-18-2020 - Update on COVID-19 7.3.2. Administration Report AD-19-2020 - Bill 197 - Proxy Voting 7.3.3. Integrity Commissioner's Report 7.4. Finance 7.4.1. Accounts 7.4.2. Finance Report FIN-10-2020 - Water and Sewer Billing Period 7.4.3. Finance Report FIN-11-2020 - User Fees for 2021-2025 7.4.4. Finance Report FIN-12-2020 - 2020 Annual Repayment Limit (ARL) 7.5. Fire Department 7.5.1. District 1 - Monthly Report - September 2020 7.5.2. District 2 - Monthly Report - September 2020 7.6. Parks & Recreation 7.6.1. REC Monthly Report - September 2020 7.7.